Siti Norlina Md Said
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Siti Norlina Md Said has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Hendrika Laetitia Hattingh
Allied Health Research, Gold Coast Hospital and Health Service, Southport, Australia
2 shared publications - Shamala Ayadurai
School of Pharmacy and Biomedical Sciences, Curtin University. Perth, WA (Australia).
2 shared publications Lisa B. G. Tee
Curtin University, School of Pharmacy, Kent Road, Bentley, Perth, WA 6102, Australia
1 shared publicationLisa B.G. Tee
School of Pharmacy and Biomedical Sciences, Faculty of Health Science Curtin University Perth Western Australia Australia
1 shared publicationV. Bruce Sunderland
School of Pharmacy and Biomedical Sciences, Faculty of Health Science Curtin University Perth Western Australia Australia
1 shared publication
Latest Publications
- 7 June 2018
- Published by Wiley in Journal of Diabetes
- Vol. 10 (12) , 965-976
Structured tool to improve clinical outcomes of type 2 diabetes mellitus patients: A randomized controlled trial
Background: Reviewing pharmacist diabetes intervention studies revealed a lack of structured process in providing diabetes care, leading to varied results from increased to minimal improvements. The aim of this study was to determine the effectiveness of the Simpler tool, a structured clinical guidelines tool, in the delivery of diabetes care. The primary outcome was significant improvement in HbA1c. Secondary outcomes were improved lipid profiles and blood pressure (BP).Methods: A 6‐month parallel multicenter two‐arm, single‐blind randomized controlled trial involving 14 pharmacists at seven primary care clinics was conducted in Johor, Malaysia. Pharmacists without prior specialized diabetes training were trained to use the tool. Patients were randomized within each center to either Simpler care (SC), receiving care from pharmacists who used the tool (n =55), or usual care (UC), receiving usual care and dispensing services (n =69).Results: Compared with UC, SC significantly reduced HbA1c (mean reduction 1.59% [95% confidence interval {CI} −2.2, −0.9] vs 0.25% [95% CI −0.62, 0.11], respectively;P≤ 0.001), and significantly improved systolic BP (−6.28 mmHg [95% CI −10.5, 2.0] vs 0.26 mmHg [95% CI −3.74, 0.43], respectively;P =0.005). A significantly higher proportion of patients in the SC than UC arm reached the Malaysian guideline treatment goals for HbA1c (14.3% vs 1.5%;P =0.020), systolic BP (80% vs 42%;P =0.001), and low‐density lipoprotein cholesterol (60.5% vs 40.4%;P =0.046).Conclusions: Using the Simpler tool facilitated the delivery of comprehensive evidence‐based diabetes management and significantly improved clinical outcomes. The Simpler tool supported pharmacists in providing enhanced structured diabetes care.
- 7 June 2018
- Published by Wiley in Journal of Diabetes
- Vol. 10 (12) , 965-976
Structured tool to improve clinical outcomes of type 2 diabetes mellitus patients: A randomized controlled trial
Background: Reviewing pharmacist diabetes intervention studies revealed a lack of structured process in providing diabetes care, leading to varied results from increased to minimal improvements. The aim of this study was to determine the effectiveness of the Simpler tool, a structured clinical guidelines tool, in the delivery of diabetes care. The primary outcome was significant improvement in HbA1c. Secondary outcomes were improved lipid profiles and blood pressure (BP).Methods: A 6‐month parallel multicenter two‐arm, single‐blind randomized controlled trial involving 14 pharmacists at seven primary care clinics was conducted in Johor, Malaysia. Pharmacists without prior specialized diabetes training were trained to use the tool. Patients were randomized within each center to either Simpler care (SC), receiving care from pharmacists who used the tool (n =55), or usual care (UC), receiving usual care and dispensing services (n =69).Results: Compared with UC, SC significantly reduced HbA1c (mean reduction 1.59% [95% confidence interval {CI} −2.2, −0.9] vs 0.25% [95% CI −0.62, 0.11], respectively;P≤ 0.001), and significantly improved systolic BP (−6.28 mmHg [95% CI −10.5, 2.0] vs 0.26 mmHg [95% CI −3.74, 0.43], respectively;P =0.005). A significantly higher proportion of patients in the SC than UC arm reached the Malaysian guideline treatment goals for HbA1c (14.3% vs 1.5%;P =0.020), systolic BP (80% vs 42%;P =0.001), and low‐density lipoprotein cholesterol (60.5% vs 40.4%;P =0.046).Conclusions: Using the Simpler tool facilitated the delivery of comprehensive evidence‐based diabetes management and significantly improved clinical outcomes. The Simpler tool supported pharmacists in providing enhanced structured diabetes care.
- Open Access
- 10 May 2016
- Published by Hindawi Limited in Journal of Diabetes Research
- Vol. 2016, 1-11
A Narrative Review of Diabetes Intervention Studies to Explore Diabetes Care Opportunities for Pharmacists
Background. We conducted a review of current diabetes intervention studies in type 2 diabetes and identified opportunities for pharmacists to deliver quality diabetes care.Methods. A search on randomised controlled trials (RCT) on diabetes management by healthcare professionals including pharmacists published between 2010 and 2015 was conducted.Results and Discussion. Diabetes management includes multifactorial intervention which includes seven factors as outlined in diabetes guidelines, namely, glycaemic, cholesterol and blood pressure control, medication, lifestyle, education, and cardiovascular risk factors. Most studies do not provide evidence that the intervention methods used included all seven factors with exception of three RCT which indicated HbA1c (glycated hemoglobin) reduction range of 0.5% to 1.8%. The varied HbA1C reduction suggests a lack of standardised and consistent approach to diabetes care. Furthermore, the duration of most studies was from one month to two years; therefore long term outcomes could not be established.Conclusion. Although pharmacists’ contribution towards improving clinical outcomes of diabetes patients was well documented, the methods used to deliver structured, consistent evidence-based care were not clearly stipulated. Therefore, approaches to achieving long term continuity of care are uncertain. An intervention strategy that encompass all seven evidence-based factors will be useful.
- 10 May 2016
- Published by Hindawi Limited in Journal of Diabetes Research
- Vol. 2016, 1-11
Open AccessA Narrative Review of Diabetes Intervention Studies to Explore Diabetes Care Opportunities for Pharmacists
Background. We conducted a review of current diabetes intervention studies in type 2 diabetes and identified opportunities for pharmacists to deliver quality diabetes care.Methods. A search on randomised controlled trials (RCT) on diabetes management by healthcare professionals including pharmacists published between 2010 and 2015 was conducted.Results and Discussion. Diabetes management includes multifactorial intervention which includes seven factors as outlined in diabetes guidelines, namely, glycaemic, cholesterol and blood pressure control, medication, lifestyle, education, and cardiovascular risk factors. Most studies do not provide evidence that the intervention methods used included all seven factors with exception of three RCT which indicated HbA1c (glycated hemoglobin) reduction range of 0.5% to 1.8%. The varied HbA1C reduction suggests a lack of standardised and consistent approach to diabetes care. Furthermore, the duration of most studies was from one month to two years; therefore long term outcomes could not be established.Conclusion. Although pharmacists’ contribution towards improving clinical outcomes of diabetes patients was well documented, the methods used to deliver structured, consistent evidence-based care were not clearly stipulated. Therefore, approaches to achieving long term continuity of care are uncertain. An intervention strategy that encompass all seven evidence-based factors will be useful.